• 23 June, 2025

Dr Reddy's launches Rapamune's generic version in the US

October 30, 2014 | Thursday | News | By BioSpectrum Bureau

Dr Reddy's launches Rapamune's generic version in the US

(Photo Courtesy: www.nordiclifescience.org)

(Photo Courtesy: www.nordiclifescience.org)

The generic drug has received approval nod from the United States Food and Drug Administration (USFDA).

The Rapamune tablets brand had US sales of approximately $206 million MAT for the most recent twelve months ending in August 2014, according to IMS Health.

Dr Reddy's Sirolimus tablets are available in 1mg and 2mg in bottle counts of 100.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s Integrated DigiTech targeting Affordable Healthcare Access?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy